CD14 and lung adenocarcinoma: In line with these results, previous studies in other carcinomas have reported a diminished percentage of TNFα-producing CD14+ cells in PB of lung adenocarcinoma patients, showing that malignant cells inhibited the capability of monocytes to produce TNFα [25].